Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

Ketamine: stimulating antidepressant treatment?

Malhi GS, Byrow Y, Cassidy F, Cipriani A, Demyttenaere K, Frye MA, Gitlin M, Kennedy SH, Ketter TA, Lam RW, McShane R, Mitchell AJ, Ostacher MJ, Rizvi SJ, Thase ME, Tohen M.

BJPsych Open. 2016 May 11;2(3):e5-e9. eCollection 2016 May.

2.

Increased Suicidal Ideation in Patients with Co-Occurring Bipolar Disorder and Post-Traumatic Stress Disorder.

Carter JM, Arentsen TJ, Cordova MJ, Ruzek J, Reiser R, Suppes T, Ostacher MJ.

Arch Suicide Res. 2016 Jun 16:1-12. doi: 10.1080/13811118.2016.1199986. [Epub ahead of print]

PMID:
27310106
3.

White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder.

Köhler O, Sylvia LG, Bowden CL, Calabrese JR, Thase M, Shelton RC, McInnis M, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Deckersbach T, Ostacher MJ, Iosifescu DV, McElroy S, Nierenberg AA.

Aust N Z J Psychiatry. 2017 Apr;51(4):355-365. doi: 10.1177/0004867416644508. Epub 2016 Jul 11.

PMID:
27126391
4.

A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder.

Sylvia LG, Gold AK, Stange JP, Peckham AD, Deckersbach T, Calabrese JR, Weiss RD, Perlis RH, Nierenberg AA, Ostacher MJ.

Am J Addict. 2016 Mar;25(2):94-8. doi: 10.1111/ajad.12346. Epub 2016 Feb 19.

5.

Florida Best Practice Psychotherapeutic Medication Guidelines for Adults With Bipolar Disorder: A Novel, Practical, Patient-Centered Guide for Clinicians.

Ostacher MJ, Tandon R, Suppes T.

J Clin Psychiatry. 2016 Jul;77(7):920-6. doi: 10.4088/JCP.15cs09841.

PMID:
26580001
6.

A clinical measure of suicidal ideation, suicidal behavior, and associated symptoms in bipolar disorder: Psychometric properties of the Concise Health Risk Tracking Self-Report (CHRT-SR).

Ostacher MJ, Nierenberg AA, Rabideau D, Reilly-Harrington NA, Sylvia LG, Gold AK, Shesler LW, Ketter TA, Bowden CL, Calabrese JR, Friedman ES, Iosifescu DV, Thase ME, Leon AC, Trivedi MH.

J Psychiatr Res. 2015 Dec;71:126-33. doi: 10.1016/j.jpsychires.2015.10.004. Epub 2015 Oct 9.

PMID:
26476489
7.

Antidepressants in Type II Versus Type I Bipolar Depression: A Randomized Discontinuation Trial.

Vöhringer PA, Ostacher MJ, El-Mallakh RS, Holtzman NS, Thommi SB, Whitham EA, Sullivan MC, Baldassano CF, Goodwin FK, Baldessarini RJ, Ghaemi SN.

J Clin Psychopharmacol. 2015 Oct;35(5):605-8. doi: 10.1097/JCP.0000000000000384.

8.

Monotherapy Antidepressant Treatment is Not Associated With Mania in Bipolar I Disorder.

Ostacher MJ, Perlis RH, Geddes J.

Am J Psychiatry. 2015 Jun;172(6):586. doi: 10.1176/appi.ajp.2015.14111443. No abstract available.

PMID:
26029807
9.

Patterns of response to aripiprazole, lithium, haloperidol, and placebo across factor scores of mania.

Ostacher MJ, Suppes T, Swann AC, Eudicone JM, Landsberg W, Baker RA, Carlson BX.

Int J Bipolar Disord. 2015 May 5;3:11. doi: 10.1186/s40345-015-0026-0. eCollection 2015.

10.

Controversies in the psychopharmacology of bipolar disorder.

Post RM, Ostacher MJ, Singh V.

J Clin Psychiatry. 2014 Nov;75(11):e30. doi: 10.4088/JCP.13095tx2cj. Review.

11.

When positive isn't positive: the hopes and disappointments of clinical trials.

Ostacher MJ.

J Clin Psychiatry. 2014 Oct;75(10):e1186-7. doi: 10.4088/JCP.14com09427. No abstract available.

12.

Alcohol and the law.

Karasov AO, Ostacher MJ.

Handb Clin Neurol. 2014;125:649-57. doi: 10.1016/B978-0-444-62619-6.00038-0. Review.

PMID:
25307602
13.

The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar disorder.

Sylvia LG, Rabideau DJ, Nierenberg AA, Bowden CL, Friedman ES, Iosifescu DV, Thase ME, Ketter T, Greiter EA, Calabrese JR, Leon AC, Ostacher MJ, Reilly-Harrington N.

J Affect Disord. 2014 Dec;169:144-8. doi: 10.1016/j.jad.2014.08.019. Epub 2014 Aug 20.

14.

A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trial.

Rabideau DJ, Nierenberg AA, Sylvia LG, Friedman ES, Bowden CL, Thase ME, Ketter TA, Ostacher MJ, Reilly-Harrington N, Iosifescu DV, Calabrese JR, Leon AC, Schoenfeld DA.

Clin Trials. 2014 Aug;11(4):494-502. Epub 2014 May 28.

15.

What can ICD-11 be that DSM-5 cannot?

Ostacher MJ.

Aust N Z J Psychiatry. 2014 Mar;48(3):283-4. doi: 10.1177/0004867414521507. No abstract available.

PMID:
24566299
16.

Pilot investigation of isradipine in the treatment of bipolar depression motivated by genome-wide association.

Ostacher MJ, Iosifescu DV, Hay A, Blumenthal SR, Sklar P, Perlis RH.

Bipolar Disord. 2014 Mar;16(2):199-203. doi: 10.1111/bdi.12143. Epub 2013 Dec 27.

PMID:
24372835
17.

Medication adherence in a comparative effectiveness trial for bipolar disorder.

Sylvia LG, Reilly-Harrington NA, Leon AC, Kansky CI, Calabrese JR, Bowden CL, Ketter TA, Friedman ES, Iosifescu DV, Thase ME, Ostacher MJ, Keyes M, Rabideau D, Nierenberg AA.

Acta Psychiatr Scand. 2014 May;129(5):359-65. doi: 10.1111/acps.12202. Epub 2013 Oct 3.

18.

Use of treatment services in a comparative effectiveness study of bipolar disorder.

Sylvia LG, Iosifescu D, Friedman ES, Bernstein EE, Bowden CL, Ketter TA, Reilly-Harrington NA, Leon AC, Calabrese JR, Ostacher MJ, Rabideau DJ, Thase ME, Nierenberg AA.

Psychiatr Serv. 2013 Nov 1;64(11):1119-26. doi: 10.1176/appi.ps.201200479.

PMID:
23945956
19.

The Medication Recommendation Tracking Form: a novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness research.

Reilly-Harrington NA, Sylvia LG, Leon AC, Shesler LW, Ketter TA, Bowden CL, Calabrese JR, Friedman ES, Ostacher MJ, Iosifescu DV, Rabideau DJ, Thase ME, Nierenberg AA.

J Psychiatr Res. 2013 Nov;47(11):1686-93. doi: 10.1016/j.jpsychires.2013.07.009. Epub 2013 Jul 30.

PMID:
23911057
20.

Presentation and prevalence of PTSD in a bipolar disorder population: a STEP-BD examination.

Hernandez JM, Cordova MJ, Ruzek J, Reiser R, Gwizdowski IS, Suppes T, Ostacher MJ.

J Affect Disord. 2013 Sep 5;150(2):450-5. doi: 10.1016/j.jad.2013.04.038. Epub 2013 May 23.

PMID:
23706842

Supplemental Content

Loading ...
Support Center